REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS. Al-Nawaiseh S, Rickmann A, Seuthe AM, Al-Rimawi D, et al. Retina 2021;41:2549-2555.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Al-Nawaiseh S, Rickmann A, Seuthe AM, Al-Rimawi D, et al. REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS. Retina 2021;41:2549-2555.
PMID: 34173361